Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)
CNY 6.47
(1.25%)
CNY 6.47
(1.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 610.29 Million CNY | -15.91% |
| 2022 | 363.78 Million CNY | -28.36% |
| 2021 | 539.84 Million CNY | 24.66% |
| 2020 | 492.84 Million CNY | -26.05% |
| 2019 | 644.61 Million CNY | -15.28% |
| 2018 | 735.51 Million CNY | 89.41% |
| 2017 | 424.39 Million CNY | -21.13% |
| 2016 | 487.75 Million CNY | -17.82% |
| 2015 | 609.53 Million CNY | -27.44% |
| 2014 | 863.73 Million CNY | 21.44% |
| 2013 | 685.73 Million CNY | 30.09% |
| 2012 | 538.21 Million CNY | 38.75% |
| 2011 | 383.59 Million CNY | 38.21% |
| 2010 | 271.39 Million CNY | 13.74% |
| 2009 | 252.38 Million CNY | -7.35% |
| 2008 | 247.83 Million CNY | 84.42% |
| 2007 | 159.01 Million CNY | 120.33% |
| 2006 | 62.79 Million CNY | 35.64% |
| 2005 | 48.38 Million CNY | 8.83% |
| 2004 | 44.45 Million CNY | 8.41% |
| 2003 | 41 Million CNY | 347.28% |
| 2002 | -16.58 Million CNY | -180.08% |
| 2001 | 20.7 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 158.77 Million CNY | 69.69% |
| 2024 Q3 | -52.99 Million CNY | -363.14% |
| 2024 Q2 | 47.65 Million CNY | -80.39% |
| 2023 Q1 | 34.66 Million CNY | -35.6% |
| 2023 Q2 | 349.28 Million CNY | 907.69% |
| 2023 Q3 | -222.73 Million CNY | -163.77% |
| 2023 Q4 | 63.54 Million CNY | 128.53% |
| 2023 FY | - CNY | -15.91% |
| 2022 Q2 | 83.57 Million CNY | -30.65% |
| 2022 Q3 | 52.54 Million CNY | -37.13% |
| 2022 Q4 | 53.81 Million CNY | 2.42% |
| 2022 FY | - CNY | -28.36% |
| 2022 Q1 | 120.51 Million CNY | -25.93% |
| 2021 Q3 | 492.61 Thousand CNY | -99.81% |
| 2021 Q4 | 162.7 Million CNY | 32929.55% |
| 2021 FY | - CNY | 24.66% |
| 2021 Q2 | 255.43 Million CNY | 245.66% |
| 2021 Q1 | 73.89 Million CNY | -54.06% |
| 2020 Q3 | 83.71 Million CNY | -51.95% |
| 2020 Q1 | 57.17 Million CNY | 65.78% |
| 2020 Q2 | 174.2 Million CNY | 204.69% |
| 2020 Q4 | 160.84 Million CNY | 92.14% |
| 2020 FY | - CNY | -26.05% |
| 2019 FY | - CNY | -15.28% |
| 2019 Q2 | 179.2 Million CNY | -10.0% |
| 2019 Q1 | 199.12 Million CNY | 103.1% |
| 2019 Q3 | 153.07 Million CNY | -14.58% |
| 2019 Q4 | 34.48 Million CNY | -77.47% |
| 2018 Q2 | 189.67 Million CNY | -5.85% |
| 2018 Q4 | 98.04 Million CNY | -54.06% |
| 2018 FY | - CNY | 89.41% |
| 2018 Q1 | 201.46 Million CNY | 410.97% |
| 2018 Q3 | 213.42 Million CNY | 12.52% |
| 2017 Q3 | 128.86 Million CNY | 48.88% |
| 2017 Q2 | 86.55 Million CNY | -19.92% |
| 2017 Q1 | 108.08 Million CNY | 17.94% |
| 2017 FY | - CNY | -21.13% |
| 2017 Q4 | 39.42 Million CNY | -69.4% |
| 2016 Q1 | 171.66 Million CNY | 29.28% |
| 2016 FY | - CNY | -17.82% |
| 2016 Q4 | 91.64 Million CNY | -5.87% |
| 2016 Q3 | 97.35 Million CNY | -14.16% |
| 2016 Q2 | 113.41 Million CNY | -33.93% |
| 2015 Q4 | 132.78 Million CNY | -27.25% |
| 2015 Q2 | 99.88 Million CNY | -41.18% |
| 2015 FY | - CNY | -27.44% |
| 2015 Q1 | 169.81 Million CNY | -36.86% |
| 2015 Q3 | 182.51 Million CNY | 82.73% |
| 2014 Q3 | 178.64 Million CNY | -8.96% |
| 2014 Q4 | 268.97 Million CNY | 50.57% |
| 2014 FY | - CNY | 21.44% |
| 2014 Q1 | 176.74 Million CNY | -16.84% |
| 2014 Q2 | 196.22 Million CNY | 11.02% |
| 2013 Q1 | 137.97 Million CNY | -2.19% |
| 2013 Q3 | 164.73 Million CNY | 0.93% |
| 2013 Q4 | 212.54 Million CNY | 29.02% |
| 2013 FY | - CNY | 30.09% |
| 2013 Q2 | 163.21 Million CNY | 18.29% |
| 2012 Q2 | 131.09 Million CNY | 22.65% |
| 2012 Q1 | 106.88 Million CNY | 10.95% |
| 2012 Q4 | 141.06 Million CNY | 1.12% |
| 2012 FY | - CNY | 38.75% |
| 2012 Q3 | 139.5 Million CNY | 6.42% |
| 2011 FY | - CNY | 38.21% |
| 2011 Q4 | 96.33 Million CNY | -5.75% |
| 2011 Q3 | 102.2 Million CNY | 11.71% |
| 2011 Q1 | 80.74 Million CNY | 48.6% |
| 2011 Q2 | 91.49 Million CNY | 13.31% |
| 2010 Q1 | 64.17 Million CNY | 26.45% |
| 2010 FY | - CNY | 13.74% |
| 2010 Q2 | 86.96 Million CNY | 35.52% |
| 2010 Q3 | 61.86 Million CNY | -28.86% |
| 2010 Q4 | 54.34 Million CNY | -12.16% |
| 2009 FY | - CNY | -7.35% |
| 2009 Q4 | 50.74 Million CNY | -32.07% |
| 2009 Q3 | 74.7 Million CNY | 14.98% |
| 2009 Q2 | 64.97 Million CNY | 46.69% |
| 2009 Q1 | 44.29 Million CNY | -10.94% |
| 2008 Q4 | 49.73 Million CNY | -39.63% |
| 2008 Q3 | 82.37 Million CNY | 19.74% |
| 2008 Q2 | 68.79 Million CNY | 27.64% |
| 2008 Q1 | 53.89 Million CNY | -31.09% |
| 2008 FY | - CNY | 84.42% |
| 2007 Q1 | 8.16 Million CNY | -64.96% |
| 2007 FY | - CNY | 120.33% |
| 2007 Q4 | 78.21 Million CNY | 270.6% |
| 2007 Q3 | 21.1 Million CNY | -33.57% |
| 2007 Q2 | 31.77 Million CNY | 289.27% |
| 2006 Q1 | -7.11 Million CNY | -111.21% |
| 2006 Q2 | 34.93 Million CNY | 590.95% |
| 2006 FY | - CNY | 35.64% |
| 2006 Q3 | 17.08 Million CNY | -51.08% |
| 2006 Q4 | 23.29 Million CNY | 36.31% |
| 2005 Q1 | -3.32 Million CNY | -105.87% |
| 2005 Q2 | 26.46 Million CNY | 895.38% |
| 2005 FY | - CNY | 8.83% |
| 2005 Q3 | -4.87 Million CNY | -118.43% |
| 2005 Q4 | 63.49 Million CNY | 1402.02% |
| 2004 Q3 | 11.97 Million CNY | -44.59% |
| 2004 Q2 | 21.6 Million CNY | 478.57% |
| 2004 Q4 | 56.65 Million CNY | 373.24% |
| 2004 FY | - CNY | 8.41% |
| 2004 Q1 | -5.7 Million CNY | -112.59% |
| 2003 Q4 | 45.34 Million CNY | 469.55% |
| 2003 FY | - CNY | 347.28% |
| 2003 Q3 | 7.96 Million CNY | 0.0% |
| 2002 FY | - CNY | -180.08% |
| 2001 FY | - CNY | 0.0% |